BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2692145)

  • 21. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up.
    Collins P; Webb CM; Chong CF; Moat NE;
    Circulation; 2008 Jun; 117(22):2859-64. PubMed ID: 18506009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
    Fremes SE; Levinton C; Naylor CD; Chen E; Christakis GT; Goldman BS
    Eur J Cardiothorac Surg; 1993; 7(4):169-80. PubMed ID: 8481254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
    Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
    Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of aortocoronary bypass patency by antiplatelet drug administration. Preliminary communication.
    Pirk J; Vojácek J; Kovác J
    Cor Vasa; 1986; 28(3):177-80. PubMed ID: 3527555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].
    Breddin HK; Uberla KK
    Verh Dtsch Ges Inn Med; 1980; 86():1338-48. PubMed ID: 7013326
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
    Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
    Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.
    Bourassa MG; Fisher LD; Campeau L; Gillespie MJ; McConney M; Lespérance J
    Circulation; 1985 Dec; 72(6 Pt 2):V71-8. PubMed ID: 3905060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study].
    Pfisterer M; Jockers G; Meier B; Schmitt HE; Stulz P; Hasse J; Grädel E; Burkart F
    Helv Chir Acta; 1987 Feb; 53(4):497-500. PubMed ID: 3494713
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of ibustrin on early aortocoronary bypass patency.
    Pirk J; Rohn V; Peregrin J
    Cor Vasa; 1990; 32(3):258-62. PubMed ID: 2209029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC).
    Sanz G; Pajarón A; Alegría E; Coello I; Cardona M; Fournier JA; Gómez-Recio M; Ruano J; Hidalgo R; Medina A
    Circulation; 1990 Sep; 82(3):765-73. PubMed ID: 2203555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Behavior of serum triglycerides, cholesterol, uric acid and sugar levels and of thrombocyte function in heart infarct patients during a 2-year therapy with acetylsalicylic acid, placebo or phenprocoumon].
    Weber E; Walter E; Pfleiderer T
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1731-5. PubMed ID: 347797
    [No Abstract]   [Full Text] [Related]  

  • 35. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
    Breddin K; Loew D; Lechner K; Uberla K; Walter E
    Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
    [No Abstract]   [Full Text] [Related]  

  • 36. Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusion.
    Weber MA; Hasford J; Taillens C; Zitzmann A; Hahalis G; Seggewiss H; Langbehn AF; Fassbender D; Buchwalsky R; Theisen K
    Am J Cardiol; 1990 Dec; 66(20):1464-8. PubMed ID: 2251993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial.
    Guiteras P; Altimiras J; Arís A; Augé JM; Bassons T; Bonal J; Caralps JM; Castellarnau C; Crexells C; Masotti M
    Eur Heart J; 1989 Feb; 10(2):159-67. PubMed ID: 2647494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
    Chesebro JH
    Thromb Res Suppl; 1990; 12():5-10. PubMed ID: 2082487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].
    Walter E; Weber E; Loew D
    Verh Dtsch Ges Inn Med; 1978; (84):1481-5. PubMed ID: 369187
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
    Brooks N; Wright J; Sturridge M; Pepper J; Magee P; Walesby R; Layton C; Honey M; Balcon R
    Br Heart J; 1985 Feb; 53(2):201-7. PubMed ID: 3881108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.